Comments

Nkarta Stock Price, Quotes and Forecasts

Q: What sector and industry does Nkarta (NKTX) operate in?

Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NKTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.91

At close: Jun 12 EDT

$1.91

0.000.00%

Pre-Market: 4:00 PM EDT

Nkarta (NKTX) Forecast

News Earnings Nkarta (NKTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Nkarta Stock Price, Quotes and Forecasts | NASDAQ:NKTX | Benzinga

Explore Nkarta stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NKTX.

Open	-
Close	-
Volume / Avg.	0 / 1.16M
Day Range	- - -
52 Wk Range	1.31 - 8.23
Market Cap	$135.53M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	13.13%
Days to Cover	18.63

Recent News

Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space

Nkarta posts a smaller Q1 loss than expected and maintains strong cash reserves while analysts debate its trial strategy and market position.

Vandana Singh

This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Avi Kapoor

Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday?

Nkarta restructures to extend its cash runway into 2029, with upcoming NKX019 clinical data readouts in H2 2025. Analysts maintain Buy ratings.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.16M
Day Range	- - -
52 Wk Range	1.31 - 8.23
Market Cap	$135.53M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	13.13%
Days to Cover	18.63

About Nkarta Inc

Sector

Health Care

Industry

Biotechnology

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, o...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Nkarta (NKTX) stock?

You can purchase shares of Nkarta (NASDAQ:NKTX) through any online brokerage.

View our list of the best stock brokerages

Who are Nkarta (NKTX) competitors?

Other companies in Nkarta’s space includes: Molecular Partners (NASDAQ:MOLN), Anixa Biosciences (NASDAQ:ANIX), Korro Bio (NASDAQ:KRRO), Elicio Therapeutics (NASDAQ:ELTX) and Sangamo Therapeutics (NASDAQ:SGMO).

What is the forecast, or price target, for Nkarta (NKTX) stock?

Nkarta has a consensus price target of $18.67.

What is the current price for Nkarta (NKTX)?

The stock price for Nkarta (NASDAQ: NKTX) is $1.91 last updated June 12, 2025 at 4:00 PM EDT.

Does Nkarta (NKTX) pay a dividend?

There are no upcoming dividends for Nkarta.

When is Nkarta (NASDAQ:NKTX) reporting earnings?

Nkarta’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is Nkarta (NKTX) going to split?

There is no upcoming split for Nkarta.

What sector and industry does Nkarta (NKTX) operate in?

Nkarta is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.